Kenpaullone
CAS No. 142273-20-9
Kenpaullone( 9-Bromopaullone | NSC-664704 )
Catalog No. M11777 CAS No. 142273-20-9
Kenpaullone (9-Bromopaullone,NSC-664704) is a potent inhibitor of CDK1/cyclin B with IC50 of 0.4 uM, also inhibited CDK2/cyclin A (IC50=0.68 uM), CDK2/cyclin E (IC50-7.5 uM) and CDK5/p25 (IC50=0.85 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 41 | In Stock |
|
5MG | 58 | In Stock |
|
10MG | 86 | In Stock |
|
25MG | 178 | In Stock |
|
50MG | 302 | In Stock |
|
100MG | 448 | In Stock |
|
500MG | 1017 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKenpaullone
-
NoteResearch use only, not for human use.
-
Brief DescriptionKenpaullone (9-Bromopaullone,NSC-664704) is a potent inhibitor of CDK1/cyclin B with IC50 of 0.4 uM, also inhibited CDK2/cyclin A (IC50=0.68 uM), CDK2/cyclin E (IC50-7.5 uM) and CDK5/p25 (IC50=0.85 uM).
-
DescriptionKenpaullone (9-Bromopaullone,NSC-664704) is a potent inhibitor of CDK1/cyclin B with IC50 of 0.4 uM, also inhibited CDK2/cyclin A (IC50=0.68 uM), CDK2/cyclin E (IC50-7.5 uM) and CDK5/p25 (IC50=0.85 uM); shows less effect on other kinases, only c-Src, CK2, ERK1/2 (IC50=15-20 uM) with IC50s less than 30 uM; displays delayed cell cycle progression in treated cells; also is a potent inhibitor of GSK-3β (IC50=23 nM), activates Nanog expression in mouse fibroblasts transduced with a subset of reprogramming factors lacking Klf4, can replace Klf4 in the reprogramming of primary and secondary fibroblasts and NPCs.
-
In Vitro——
-
In Vivo——
-
Synonyms9-Bromopaullone | NSC-664704
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK1/CyclinB|CDK2/CyclinA|CDK2/CyclinE|CDK5/p35|GSK-3β
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number142273-20-9
-
Formula Weight327.1754
-
Molecular FormulaC16H11BrN2O
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 35 mg/mL
-
SMILESO=C(NC1=CC=CC=C12)CC3=C2NC4=C3C=C(Br)C=C4
-
Chemical NameIndolo[3,2-d][1]benzazepin-6(5H)-one, 9-bromo-7,12-dihydro-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zaharevitz DW, et al. Cancer Res. 1999 Jun 1;59(11):2566-9.
2. Schultz C, et al. J Med Chem. 1999 Jul 29;42(15):2909-19.
3. Bain J, et al. Biochem J. 2003 Apr 1;371(Pt 1):199-204.
4. Lyssiotis CA, et al. Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):8912-7.
molnova catalog
related products
-
IIIM-290
IIIM-290 is a potent, orally active cyclin-dependent kinase (CDK) inhiitor with IC50 of 1.9 and 16 nM for Cdk-9/T1 and Cdk-2/A, respectively.
-
NG-52
NG 52 (Compound 52 ) is a potent, cell-permeable, reversible, selective, and ATP-compatible inhibitor of the cell cycle-regulating kinase.
-
CDK9-IN-2
CDK9-IN-2 is a potent and selective CDK9 inhibitor with IC50 of <8 nM, example 4 in patent WO2011026917A1.